Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors

Documenti analoghi

• Research progress of adoptive tumor infiltrating lymphocyte therapy for cervical cancer
  di: Juncheng Zhang, et al.
  Pubblicazione: (2025)
• Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
  di: Jie Hu, et al.
  Pubblicazione: (2024)
• Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
  di: Charles Swanton, et al.
  Pubblicazione: (2025)
• Tumour‐infiltrating lymphocytes, tertiary lymphoid structures and myxoid stroma predict upstaging of ductal carcinoma in situ in breast biopsies
  di: Chung‐Yen Huang, et al.
  Pubblicazione: (2025)
• Automating tumor-infiltrating lymphocyte assessment in breast cancer histopathology images using QuPath: a transparent and accessible machine learning pipeline
  di: Tafavvoghi, Masoud, et al.
  Pubblicazione: (2025)